Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025)
Anbio Biotechnology's quarterly Total Current Liabilities came in at $87836.0 in Q4 2025, down 94.92% year-on-year from $1.7 million in Q4 2024, and down 94.92% quarter-over-quarter from $1.7 million in Q4 2024.
Anbio Biotechnology has reported Total Current Liabilities for 3 years, with the latest figure at $87836.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities fell 94.92% year-over-year to $87836.0; the trailing twelve-month figure through Dec 2025 stood at $87836.0 (down 94.92% YoY), and the FY2025 full-year result was $87836.0, down 94.92% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $87836.0, down from $1.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $1.7 million in Q4 2024, with the low at $87836.0 in Q4 2025.
- Average Total Current Liabilities over 3 years is $937043.3, with a median of $993060.0 recorded in 2023.
- Year-over-year, Total Current Liabilities soared 74.23% in 2024 and slumped 94.92% in 2025.
- Tracing NNNN's Total Current Liabilities over 3 years: stood at $993060.0 in 2023, then soared by 74.23% to $1.7 million in 2024, then tumbled by 94.92% to $87836.0 in 2025.
- The last three Total Current Liabilities figures came in at $87836.0 (Q4 2025), $1.7 million (Q4 2024), and $993060.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 1.35 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 674.00 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 3.35 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 1.60 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 1.91 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 3.69 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 1.06 Bn |
| 10 | Anbio Biotechnology | 1.32 Bn | 1.31 Bn | - | 87,836.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 87,836.00 |
| Jun 30, 2025 | 131.13 Bn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 993,060.00 |